Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00393-021-00966-9 http://scihub22266oqcxt.onion/10.1007/s00393-021-00966-9 33528655!7852047!33528655     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33528655&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Z+Rheumatol 2021 ; 80 (2): 158-164 Nephropedia Template TP {{tp|p=33528655|t=2021. Aktueller Stand der Impfung gegen SARS-CoV-2 |pdf=|usr=}}{{33528655}} gab.com Text Aktueller Stand der Impfung gegen SARS-CoV-2 JO: Z Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33528655 #FOAvip On 21 December 2020 the European Medicines Agency (EMA) approved the mRNA vaccine BNT162b2 (Comirnaty(R), BioNTech, Mainz, Germany; Pfizer, New York City, NY, USA) as the first vaccine against SARS-CoV?2 in the European Union and the second vaccine (Moderna(R), Moderna, Cambridge, MA, USA) followed on 6 January 2021. Many more approvals will follow within a short period of time. With the availability of the vaccination many questions have arisen for patients as well as for physicians, which are addressed as up to date as possible in this hot topic article. Twit Text FOAVip Aktueller Stand der Impfung gegen SARS-CoV-2 ????Z Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33528655 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33528655 #FOAvip English Wikipedia <ref>{{Cite pmid|33528655}}</ref> Aktueller Stand der Impfung gegen SARS-CoV-2 #MMPMID33528655 Iking-Konert C; Specker C; Kruger K; Schulze-Koops H; Aries P Z Rheumatol 2021[Mar]; 80 (2): 158-164 PMID33528655show ga On 21 December 2020 the European Medicines Agency (EMA) approved the mRNA vaccine BNT162b2 (Comirnaty(R), BioNTech, Mainz, Germany; Pfizer, New York City, NY, USA) as the first vaccine against SARS-CoV?2 in the European Union and the second vaccine (Moderna(R), Moderna, Cambridge, MA, USA) followed on 6 January 2021. Many more approvals will follow within a short period of time. With the availability of the vaccination many questions have arisen for patients as well as for physicians, which are addressed as up to date as possible in this hot topic article. |*COVID-19[MESH] |*SARS-CoV-2[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines[MESH] |Germany[MESH] |Humans[MESH]Aktueller Stand der Impfung gegen SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing